Management and Executive

Ataraxis AI: $20.4 Million (Series A) Raised For Transforming Precision Medicine In Cancer Care

Ataraxis AI Raises $20.4 Million in Series A Led by AIX Ventures

Ataraxis AI to Transform Precision Medicine in Cancer Care with $20.4 Million Series A

#NYCtech Week in Review: 1/5/25 – 1/11/25

Research Engineer (Systems/Optimization)

Ataraxis AI is an AI precision medicine company focused on transforming cancer treatment through advanced multi-modal artificial intelligence. The Research Engineer will implement machine learning models and methods, optimize code for performance, and collaborate with a multidisciplinary team to enhance healthcare solutions.

Sign up with Google

Sign in with Google